Delivery Order SPE2DU25D4210-SPE2DU26FA948
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp on November 17, 2025, for pharmaceutical products and medical supplies under the Pharmaceutical Prime Vendor Global Program. This firm fixed-price delivery order, with an ultimate completion date of November 18, 2025, represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.18 to AmerisourceBergen Drug Corp on December 9, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order, which is not set-aside and issued on a competitive basis, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed...
- The Defense Logistics Agency awarded a $169,397.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for pharmaceutical products and medical supplies. This is an unset-aside, competitively awarded delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,620.63 to AmerisourceBergen Drug Corp on November 24, 2025, for pharmaceutical products and medical supplies under the Pharmaceutical Prime Vendor Division. This firm fixed price, competitively awarded contract (no set-aside designation) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.61 to AmerisourceBergen Drug Corp on December 13, 2025, under the Pharmaceutical Prime Vendor Global Program. This firm fixed-price delivery order, with a completion date of December 15, 2025, represents a child contract action within AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $1,098.73 to AmerisourceBergen Drug Corp on December 8, 2025, under its Pharmaceutical Prime Vendor Global Program contract vehicle. This firm fixed-price delivery order, which is not set-aside, represents a child contract action against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $12,467.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where the products will be delivered. This firm fixed price delivery order, awarded on December 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involved no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,228.92 to AmerisourceBergen Drug Corp on December 23, 2025, for pharmaceutical products and medical supplies under the Pharmaceutical Prime Vendor program. This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $24,857.18 to AmerisourceBergen Drug Corp on December 26, 2025, for pharmaceutical supply fulfillment under a firm fixed-price contract. This non-set-aside award represents a child order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical prime vendor agreement running through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.50 to AmerisourceBergen Drug Corp on November 4, 2025, under the Pharmaceutical Prime Vendor Global Program. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order represents a non-competitive award under an existing firm fixed-price contract vehicle, consistent...
- SPE2DU25D4210Indefinite Delivery Contract
- SPE2DU25D4210-SPE2DU26FA948Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,523.18 to AmerisourceBergen Drug Corp on December 4, 2025, for pharmaceutical products and medical supplies through the Pharmaceutical Prime Vendor Global Program. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's DLA contract vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains—to support military healthcare programs worldwide and federal customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts through multiple awards across separate regions, positioning AmerisourceBergen as a key supplier within this strategic procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/3/25 |